IRCT201601022394N19已完成3 期
Effects of resveratrol supplementation on serum irisin and adiponectin in patients with type 2 diabetes
Vice chancellor for research, Iran University of Medical Sciences0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 years 至 70 years（—）
- 性别
- All
入选标准
- •diagnosis of type 2 Diabetes for at least 2 years; willing to participate; BMI more than 25; age between 45 to 70 years old. Exclusion criteria: Significant diseases including cardiovascular, renal and liver diseases, or cancer; pregnancy; lactation; insulin use; weight and BMI change; consumption of nutritional supplements within the past 8 weeks.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Evaluation of the effects of Resveratrol on serum TNF-a and hs-CRPand quality of life in patients with ulcerative colitis.ulcerative colitis.Ulcerative colitis, unspecifiedIRCT201209154010N10ational Nutrition and Food Technology Research Institute (NNFTRI)50
已完成
3 期
The effect of resveratrol on diabetes treatmentType 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT2015072523336N1Vice chancellor of Research, Tehran University of Medical Sciences60
已完成
3 期
The effect of resveratrol on diabetes treatmentType 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT2015080223336N2Vice chancellor of Research, Tehran University of Medical Sciences, Dr. Masoud Younesian60
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
招募中
3 期
Resveratrol in multiple sclerosisMultiple sclerosisMultiple Sclerosis.IRCT20230315057731N1Ahvaz University of Medical Sciences60